Xeljanz (Tofacitinib) Medication for Ulcerative Colitis

XELJANZ® (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis

tofacitinibOn May 30th, 2018, the Pfizer corporation, announced that the Food and Drug Administration (FDA) has approved its application to allow for Xeljanz to be used by ulcerative colitis patients who meet certain criteria.

There are some more details listed on the Pfizer website about this new medicinal product of theirs.  You can read the full press release here:  https://press.pfizer.com/press-release/pfizer-announces-us-fda-approves-xeljanz-tofacitinib-treatment-moderately-severely-act

What would be excellent is for the current and future UC’ers of the world who have experience with Xeljanz (Tofacitinib) to start including their reviews of this on this page, both reviews of how it went, and as well any potential side effects.

Search Side Effects Below:

CLICK HERE to add any side-effects you’ve experienced.

Medication
Age
Other Meds
Date





Click here to submit your review.


Submit your review
* Required Field

One Response to Xeljanz (Tofacitinib) Medication for Ulcerative Colitis

  1. Marty Vaughn September 7, 2018 at 4:44 am #

    Has anyone taken 6-MP for UC? It had not been approved by the FDA for the use for UC. It is used for leukemia.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.